Artificial blood vessels-clinical development of TEVG.

IF 1.3 4区医学 Q4 ENGINEERING, BIOMEDICAL

Journal of Artificial Organs Pub Date : 2025-09-01 Epub Date: 2025-05-26 DOI:10.1007/s10047-025-01508-9

Manabu Itoh, Keiji Kamohara, Koichi Node, Koichi Nakayama

引用次数: 0

Abstract

The market for small-diameter vascular grafts (< 6 mm) used in cardiac and vascular surgery has not yet been fully established, as stable long-term patency has not been achieved. This paper focuses on the clinical development of tissue-engineered vascular grafts (TEVGs), especially those that have progressed to clinical trials, and introduces their current status with historical background and future directions. This review was created based on a translation of the Japanese review first reported in the Japanese Journal of Artificial Organs in 2023 (vol. 52, no. 3, pp. 161-166), with some modifications.

Abstract Image

查看原文本刊更多论文

人工血管- TEVG的临床发展。

小直径血管移植市场(

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Artificial Organs 医学-工程：生物医学

CiteScore

2.80

自引率

15.40%

发文量

审稿时长

6-12 weeks

期刊介绍： The aim of the Journal of Artificial Organs is to introduce to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. The scope of the Journal of Artificial Organs encompasses but is not restricted to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs. Additionally, the journal will cover technical and industrial innovations. Membership in the Japanese Society for Artificial Organs is not a prerequisite for submission.